Group B Streptococcus (GBS) causes serious and fatal infections in newborns and is the leading cause of neonatal sepsis and meningitis.
In this webinar co-hosted by the Centre for Vaccine Preventable Diseases, Eliana Castillo, Kirsty Le Doare and Ziyaad Dangor will discuss the latest clinical findings on GBS vaccine candidates and outline a path to vaccine commercialization.
Date and time: April 8, noon EDT
Location: Virtual on Zoom